posted
Ok for all of us who missed the run on NVAX, there seems to be hope in MCET, specially at the current dip of .72!!
------------
Press Release Source: MultiCell Technologies, Inc.
MultiCell Immunotherapeutics Data Demonstrates Potential to Prevent Avian Flu Friday October 21, 9:00 am ET Pre-Clinical Mouse Models Show 1,000-fold Reduction in Viral Load in H1N1 Strain
LINCOLN, R.I.--(BUSINESS WIRE)--Oct. 21, 2005--MultiCell Technologies, Inc. (OTCBB: MCET - News) announced today that pre-clinical tests conducted by scientists at MultiCell's San Diego laboratories showed that MultiCell Immunotherapeutics, Inc.'s (MCTI's) toll receptor technology was able to reduce pulmonary virus titers by 1,000- fold in the H1N1 strain of flu to barely detectable levels. These results indicate that the technology may be able to reduce viral load in avian influenza. The H5N1 avian flu contains many of the same proteins as the H1N1 strain of flu, so the HINI results are projected to be important to the understanding of developing an immunotherapeutic against avian flu.
Posts: 137 | Registered: Dec 2004
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
